WINTON MATTHEW (Chief Commercial and Business) purchased 50.0% of their position (5K shares) of CERVOMED INC. on the open market
Open‑market purchase worth $41.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/19/2025ACC: 0001437749-25-035655
Officer· Chief Commercial and Business
Since Feb 2026
+5K
Net shares
Net buyer
$41.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.50K
Price / share
$8.43
Trade value
$29.50K
% of position
35.0%
11/17/2025
10K→13.50K
Common Stock
Direct
Shares
+1.50K
Price / share
$7.95
Trade value
$11.93K
% of position
11.1%
11/18/2025
13.50K→15K
Total
Net shares
+5K
Net value
$41.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | P · Purchase | +3.50K | $8.43 | $29.50K | 35.0% | 10K | 13.50K |
| Common Stock Direct | 11/18/2025 | P · Purchase | +1.50K | $7.95 | $11.93K | 11.1% | 13.50K | 15K |
| Total | +5K | $41.43K | ||||||
Derivative Transactions0
No derivative transactions reported